Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Asep Medical Holdings Inc C.ASEP

Alternate Symbol(s):  SEPSF

ASEP Medical Holdings Inc. is a Canada-based company, which is in the business of acquiring research and development assets, technologies and/or businesses in the area of life sciences and medical diagnostics. The Company’s consolidates three development-stage companies, including Sepset Biosciences Inc., ABT Innovations Inc., and SafeCoat Medical Inc. It provides medical devices with an anti-microbial, antifouling coating through its SafeCoat Medical Inc. The Company also provides diagnostic kits for predicting the onset of severe Sepsis and organ failure through its Sepset Biosciences Inc. The Company also offers peptide technology through its ABT Innovations Inc. Its technology includes diagnostic and therapeutic. It has developed a novel diagnostic assay for the early and rapid diagnosis of sepsis, based on the detection of molecular signatures of sepsis specific to the immune response, rather than the presence of a pathogen.


CSE:ASEP - Post by User

Post by stockpatrolon Dec 03, 2021 7:44pm
72 Views
Post# 34197294

$ASEP.c

$ASEP.c

$ASEP.c is creating ingenious solutions for therapeutic and diagnostic problems in healthcare. 

 

One of the main issues with diagnostics is that blood cultures take 24Hrs for every result, with every hour delay of proper treatment increases probability of death by 7.6% 

 

The issue with treatment right now is that there is no effective solution for biofilms, which causes 65% of all infections. 

 

$ASEP.c ’s proprietary peptide technology provides a broad spectrum efficacy against Bactria growing antibiotic-resistant biofilms. 

 

$ASEP.c has had a rough first week since listing not too long ago, however the inherent value in their peptide solution provides a perfect catalyst for $ASEP.c to receive funding. 

 

https://ca.finance.yahoo.com/quote/ASEP.CN/community?p=ASEP.CN&.tsrc=fin-srch

<< Previous
Bullboard Posts
Next >>